Sharepoint Solutions
PRODUCTS
-
Accelerate your drug development with our comprehensive pre-formulation, formulation, and novel delivery system expertise, tailored to optimize physical form, enhance solubility, and support scale-up.
-
AES Box™ is a modular architectural system that delivers our best-in-class modular cleanroom design and integrates seamlessly with your current project infrastructure while providing the compliance and quality you need.
-
Biotech companies progressing through clinical trials, planning an IPO, and undergoing rapid growth have a unique set of financial, contract, compliance, and reporting needs. We have designed an ERP solution, built on NetSuite, to address all of these needs. With over 50 implementations in the last two years alone, SuiteSuccess for Life Sciences is quickly becoming the defacto software standard for all successful biotechnology companies.
-
Used Kikusui tablet in tablet press, model Aquarius G-J/DC, 36 station, keyed upper punch guides, B tooled, 100 kN pre-compression, 100 kN main compression, 16mm max tablet diameter, 18mm max depth of fill, rated up to 259,200 tablets/hour, with DC module for core feeder, 4-15mm core depth adjustment, with integrated primary and secondary powder feed hoppers, and core feed hopper, project# 1-6302, built 2009.
-
Perfluoroalkyl and polyfluoroalkyl substances (PFAS) and emerging contaminants don’t break down easily, making them difficult to remove from our water sources. Newterra offers pre-engineered adsorber filtration systems for effective removal at any flow rate.
WHITE PAPERS AND CASE STUDIES
-
Designing More Representative Trials Through Strategic Planning
Strategic planning for representative clinical trials improves outcomes, regulatory alignment, recruitment efficiency, and commercial value by ensuring study populations mirror real-world patients.
-
The Effect Of Conventional Cooling Versus Controlled Ice Nucleation On Primary Drying Time
See how controlled ice nucleation shortens lyophilization cycles, supports higher drying temperatures, and reduces complexity for amorphous and mixed formulations without sacrificing quality.
-
Rescuing A Global Program For NDA Success
Explore the collaboration that enabled FDA approval of a novel chronic-condition therapy, rescued a high-risk program, and demonstrated a unified “one-team” approach by reworking the sponsor's SAP.
-
Unveiling The Critical Role of Sleep In Clinical Studies
Explore the critical role of sleep in clinical trials and its impact on health outcomes, emphasizing the need to address sleep disturbances for more effective and reliable research.
-
Expert Consulting And MRCT Strategy Rescues Oncology Program
Uncover how this strategic approach yielded significant outcomes, including uncovering missing data through IB review, streamlining dosing timelines, and achieving successful recruitment milestones.
-
Development Of A Non-Standard Protein Therapeutic
Discover how a tailored development approach transformed a complex therapeutic protein into a candidate ready for early-stage clinical trials.
-
Biostatistics And Programming — More Than Just Clinical Trials
See how our biostatisticians and programmers successfully ingested, cleaned, and analyzed the data, ultimately providing a small biotech company with several interesting and actionable measures.
-
Thales Receives Custom 10PW Beam Dump For World's Most Powerful Laser
By collaborating with Gentec-EO and their distributor Laser Components, see how Thales was able to gather the necessary specifications and requirements for this project.
-
Increasing Batch Size And Reducing Cycle Times For A Biologic
JHS partnered with a global pharma company to optimize biologic production, increasing output by 50% and reducing batch release times by up to 30%.
-
Flexible Integrations To Reduce Risks And Increase Efficiencies
Learn how a trial team kept the blind of central lab samples and patient treatment across a Phase III and extension trial, whilst optimizing the supply chain.
-
Avoiding The Pitfalls Of PQR
Explore the fundamentals of Product Quality Reviews (PQRs), common challenges manufacturers face, strategies for streamlining PQRs, and solutions that aim to unlock the potential of a "real-time PQR."
-
Fortrea Optimizes Site Matching On Retina Clinical Trials
Faced with challenges in engaging clinical trial sites within the retina research landscape, Fortrea sought a partnership that leverages RWD to streamline site feasibility assessments.
NEWS
-
'A More Versatile And Powerful Foundation For Future Photonic Technologies'6/24/2025
The candidate pool for engineered materials that can help enable tomorrow’s cutting-edge optical technologies—such as lasers, detectors and imaging devices—is much deeper than previously believed.
-
WaterEquity's Everspring Fund Expands Household Access To Water And Sanitation Across Emerging Markets3/19/2026
On World Water Day 2025, we announced the creation of the WaterEquity Everspring Fund, which launched four months later.
-
EPA Announces $7 Billion In Newly Available WIFIA Funding And Five New WIFIA Loan Approvals11/20/2025
The U.S. Environmental Protection Agency (EPA) has announced $6.5 billion in Water Infrastructure Finance and Innovation Act (WIFIA) funding available for water systems, with an additional $550 million available to states. Interested entities can apply for this funding through a rolling application process.
-
Pittsburgh Water Receives $26M In Grants And Low-Interest Loans From PENNVEST1/23/2025
Today, Pittsburgh Water announced the receipt of $26M in grants and low-interest loans from the Pennsylvania Infrastructure Investment Authority (PENNVEST) to continue the diligent removal of lead service lines throughout Pittsburgh’s drinking water system.
-
Greenwater Services Pilot Achieves 91.5% Reduction In Total Coliform Bacteria In Tijuana River Project3/17/2026
Greenwater Services, a water technology company specializing in environmentally safe water treatment and purification technologies, announced that its five-week pilot project on the Tijuana River achieved an average 91.5% reduction in total coliform bacteria on treatment days, significantly exceeding the project’s initial 15-20% performance objectives.